Fda Declares - QuikReader

FDA declares end to Wegovy and Ozempic shortage

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

CBS News - 1d

Brazilian city in Amazon declares emergency after huge sinkholes appear

In Buriticupu, about 1,200 people risk losing their homes, and residents have seen the problem escalate in 30 years. Authorities in a city in the Brazilian Amazon have declared a state of ...

The Guardian - 1d

FDA’s Food Safety Chief Resigns

The chief said the loss of critical employees overseeing the nation’s food supply made his work impossible. Robert F. Kennedy Jr., the nation’s new health secretary, has pledged to gut the division.

The New York Times - 4d

Top FDA official resigns, warns firings will backfire on RFK Jr.

James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda."

CBS News - 1d

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

MarketWatch - 1d

Ozempic and Wegovy officially moved off FDA's drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...

The Hill - 1d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

CNBC - 1d

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.

Inc. - 5h

Firings at FDA Decimated Teams for AI and Food Safety. Those Hires Are Now Gone.

Teams evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.

The New York Times - 1d

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage